Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2

This publication has 34 references indexed in Scilit:

• Preclinical development of CAT‐354, an IL‐13 neutralizing antibody, for the treatment of severe uncontrolled asthma
  British Journal of Pharmacology, 2011
• Overview of theCCP4 suite and current developments
  Acta Crystallographica Section D Structural Biology, 2011
• Human Framework Adaptation of a Mouse Anti-Human IL-13 Antibody
  Journal of Molecular Biology, 2010
• Features and development of Coot
  Acta Crystallographica Section D Structural Biology, 2010
• Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 System
  Cell, 2008
• Phasercrystallographic software
  Journal of Applied Crystallography, 2007
• Probing a protein–protein interaction by in vitro evolution
  Proceedings of the National Academy of Sciences, 2006
• Refinement of Macromolecular Structures by the Maximum-Likelihood Method
  Acta Crystallographica Section D Structural Biology, 1997
• [20] Processing of X-ray diffraction data collected in oscillation mode
  1997
• Shape Complementarity at Protein/Protein Interfaces
  Journal of Molecular Biology, 1993